Arrow Financial’s Incyte INCY Stock Holding History

Arrow Financial’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-13	Closed	-$1K	–	418
2015 Q4	$1K	Buy	+13	New	+$1.45K	﹤0.01%	484

Other funds holding INCY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Arrow Financial's INCY Position: Q1 2016 in Review

Arrow Financial sold out of Incyte (INCY) in Q1 2016, closing a stake of 13 shares — an estimated $1K sold.

Arrow Financial first reported a position in INCY in Q4 2015 and held it in 1 quarter. The position peaked at $1K in Q4 2015. 358 funds tracked by Wall St. Rank hold INCY as of Q1 2016.

Arrow Financial reported no remaining Incyte position as of Q1 2016 after selling out during the quarter.
Arrow Financial sold 13 Incyte shares in Q1 2016, an estimated $1K.
Arrow Financial first reported a position in Incyte in Q4 2015 and held it in 1 quarter.
Arrow Financial's Incyte position peaked at $1K in Q4 2015.
358 funds tracked by Wall St. Rank held Incyte as of Q1 2016.

Based on Arrow Financial's 13F filing for Q1 2016, filed 4 May 2016.